Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6159299 | The Journal of Urology | 2012 | 6 Pages |
Abstract
Excellent prostate cancer specific survival was demonstrated up to 30 years after surgery. Clinical risk categories and pathological tumor features were significant predictors of long-term disease specific outcomes, supporting their ongoing use in risk stratification and management decisions. Anatomical radical retropubic prostatectomy continues to represent the gold standard in the surgical management of clinically localized prostate cancer to which alternate treatment options should be compared.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Jeffrey K. Mullins, Zhaoyong Feng, Bruce J. Trock, Jonathan I. Epstein, Patrick C. Walsh, Stacy Loeb,